Cargando…
Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19
Thromboembolic events are frequently reported in patients infected with the SARS-CoV-2 virus. The exact mechanisms of COVID-19-associated hypercoagulopathy, however, remain elusive. Recently, we observed that platelets (PLTs) from patients with severe COVID-19 infection express high levels of procoa...
Autores principales: | Zlamal, Jan, Althaus, Karina, Jaffal, Hisham, Häberle, Helene, Pelzl, Lisann, Singh, Anurag, Witzemann, Andreas, Weich, Karoline, Bitzer, Michael, Malek, Nisar, Göpel, Siri, Bösmüller, Hans, Gawaz, Meinrad, Mirakaj, Valbona, Rosenberger, Peter, Bakchoul, Tamam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580563/ https://www.ncbi.nlm.nih.gov/pubmed/34753174 http://dx.doi.org/10.1182/bloodadvances.2021005210 |
Ejemplares similares
-
Antibody-induced procoagulant platelets in severe COVID-19 infection
por: Althaus, Karina, et al.
Publicado: (2021) -
The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
por: Singh, Anurag, et al.
Publicado: (2022) -
Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023) -
Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent
por: Pelzl, Lisann, et al.
Publicado: (2022) -
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins
por: O'Connor, Marie N., et al.
Publicado: (2009)